• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者的QT间期校正

QT interval correction in patients with cirrhosis.

作者信息

Zambruni Andrea, Di Micoli Antonio, Lubisco Alessandro, Domenicali Marco, Trevisani Franco, Bernardi Mauro

机构信息

Department of Internal Medicine, Cardioangiology and Hepatology, Policlinico S. Orsola-Malpighi Alma Mater Studiorum, University of Bologna, Bologna, Italy.

出版信息

J Cardiovasc Electrophysiol. 2007 Jan;18(1):77-82. doi: 10.1111/j.1540-8167.2006.00622.x.

DOI:10.1111/j.1540-8167.2006.00622.x
PMID:17229304
Abstract

INTRODUCTION

QT interval prolongation is a common electrophysiological abnormality in patients with cirrhosis. As QT interval varies with the heart rate, many QT correction formulas have been proposed, the Bazett's one being the most criticized because it over-corrects the QT interval and may be misleading. This study focused on the QT-RR relationship in patients with cirrhosis to derive a population-specific QT correction formula.

METHODS

One hundred cirrhotic patients of different etiology and severity and 53 healthy controls comparable for age and sex were enrolled. The QT-RR relationship was analyzed in patients by five regression analysis models to derive the population-specific QT-RR equation. The QTc was calculated and compared with those calculated by four common QT correction formulas (Bazett, Fridericia, Framingham, and Hodges). The correlation coefficient QTc-RR was calculated as a measure of the independence of QTc from the original RR interval.

RESULTS

In patients the QT-RR relationship was best described by the power equation "QT = 453.65 x RR1/3.02" (R2 = 0.41), similar to the Fridericia's formula. Bazett's formula led to the longest QTc (P < 0.0001), which was still significantly influenced by the RR interval (R = -0.39; P < 0.0001), while the estimated equation led to a QTc value not influenced by RR (R = -0.014).

CONCLUSION

Bazett's correction should be avoided in patients with cirrhosis because it still provides a rate-dependent QTc value and might be misleading, particularly when assessing the overall preoperative cardiac risk and the effect of drugs affecting the QT interval. In its place, our formula or that of Fridericia can be confidently employed.

摘要

引言

QT间期延长是肝硬化患者常见的电生理异常。由于QT间期随心率变化,人们提出了许多QT校正公式,其中Bazett公式受到的批评最多,因为它过度校正QT间期,可能会产生误导。本研究聚焦于肝硬化患者的QT-RR关系,以推导特定人群的QT校正公式。

方法

纳入100例不同病因和严重程度的肝硬化患者以及53例年龄和性别匹配的健康对照。通过五种回归分析模型分析患者的QT-RR关系,以推导特定人群的QT-RR方程。计算校正QT间期(QTc),并与四种常用QT校正公式(Bazett、Fridericia、Framingham和Hodges)计算的结果进行比较。计算QTc-RR相关系数,以衡量QTc与原始RR间期的独立性。

结果

在患者中,QT-RR关系用幂方程“QT = 453.65 x RR1/3.02”(R2 = 0.41)描述最佳,类似于Fridericia公式。Bazett公式导致最长的QTc(P < 0.0001),其仍受RR间期显著影响(R = -0.39;P < 0.0001),而估计方程得出的QTc值不受RR影响(R = -0.014)。

结论

肝硬化患者应避免使用Bazett校正,因为它仍提供心率依赖性QTc值,可能会产生误导,特别是在评估术前总体心脏风险和影响QT间期的药物效果时。取而代之的是,可以放心采用我们的公式或Fridericia公式。

相似文献

1
QT interval correction in patients with cirrhosis.肝硬化患者的QT间期校正
J Cardiovasc Electrophysiol. 2007 Jan;18(1):77-82. doi: 10.1111/j.1540-8167.2006.00622.x.
2
QT interval in normal infants during sleep with concurrent evaluation of QT correction formulae.正常婴儿睡眠期间的QT间期及QT校正公式的同步评估
Med Sci Monit. 2002 May;8(5):CR351-6.
3
Electrocardiographic biomarkers of ventricular repolarisation in a single family of short QT syndrome and the role of the Bazett correction formula.一个短QT综合征家系中心室复极的心电图生物标志物及Bazett校正公式的作用
Am J Cardiol. 2008 Mar 15;101(6):855-60. doi: 10.1016/j.amjcard.2007.10.049. Epub 2008 Feb 21.
4
Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.QT校正公式对报告的β2受体激动剂诱导的QTc延长影响的文献综述和初步研究。
Clin Ther. 2006 Apr;28(4):582-90. doi: 10.1016/j.clinthera.2006.04.010.
5
Heart rate correction of the QT duration in rats.大鼠 QT 间期的心率校正。
Eur J Pharmacol. 2010 Sep 1;641(2-3):187-92. doi: 10.1016/j.ejphar.2010.05.038. Epub 2010 Jun 8.
6
Gender-specific comparison of five QT correction formulae in middle-aged participants in an atherosclerosis prevention program.动脉粥样硬化预防项目中年参与者中五种QT校正公式的性别特异性比较。
Med Sci Monit. 2007 Apr;13(4):CR165-71.
7
Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.样本量、效能计算及其对药物诱导的QT间期延长深入研究成本的影响。
Pacing Clin Electrophysiol. 2004 Dec;27(12):1659-69. doi: 10.1111/j.1540-8159.2004.00701.x.
8
Heart rate-dependence of QTc intervals assessed by different correction methods in patients with normal or prolonged repolarization.正常或延长复极患者中不同校正方法评估的QTc间期的心率依赖性
Pacing Clin Electrophysiol. 2010 May;33(5):553-60. doi: 10.1111/j.1540-8159.2009.02657.x. Epub 2009 Dec 18.
9
The best QT correction formula in a non-hospitalized population: the Fasa PERSIAN cohort study.最佳 QT 校正公式在非住院人群中的应用:Fasa PERSIAN 队列研究。
BMC Cardiovasc Disord. 2022 Feb 16;22(1):52. doi: 10.1186/s12872-022-02502-2.
10
Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.将心率校正公式应用于犬QT间期所引入的误差幅度。
Ann Noninvasive Electrocardiol. 2006 Oct;11(4):289-98. doi: 10.1111/j.1542-474X.2006.00120.x.

引用本文的文献

1
Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies.移植前肝硬化患者的心脏重塑与心律失常负担:病理生理机制与管理策略
Biomedicines. 2025 Mar 28;13(4):812. doi: 10.3390/biomedicines13040812.
2
Propranolol can correct prolonged QT intervals in patients with cirrhosis.普萘洛尔可纠正肝硬化患者延长的QT间期。
Front Pharmacol. 2024 Apr 26;15:1370261. doi: 10.3389/fphar.2024.1370261. eCollection 2024.
3
Cardiomyopathy in cirrhosis: From pathophysiology to clinical care.
肝硬化中的心肌病:从病理生理学到临床护理
JHEP Rep. 2023 Sep 23;6(1):100911. doi: 10.1016/j.jhepr.2023.100911. eCollection 2024 Jan.
4
Corrected QT interval in cirrhosis: A systematic review and meta-analysis.肝硬化患者的校正QT间期:一项系统评价与荟萃分析。
World J Hepatol. 2023 Sep 27;15(9):1060-1083. doi: 10.4254/wjh.v15.i9.1060.
5
Prolonged QT Interval in Cirrhosis: Twisting Time?肝硬化患者的 QT 间期延长:扭转乾坤?
Gut Liver. 2022 Nov 15;16(6):849-860. doi: 10.5009/gnl210537. Epub 2022 Jul 22.
6
What's New in Cirrhotic Cardiomyopathy?-Review Article.肝硬化性心肌病有哪些新进展?-综述文章。
J Pers Med. 2021 Dec 3;11(12):1285. doi: 10.3390/jpm11121285.
7
Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients.低高密度脂蛋白胆固醇水平与乙型肝炎相关失代偿性肝硬化患者不良预后的关系。
Biomed Res Int. 2021 Jul 27;2021:9927330. doi: 10.1155/2021/9927330. eCollection 2021.
8
Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.肝硬化心肌病 QT 间期延长与结构异常的关系:当前范式的改变。
Am J Transplant. 2021 Jun;21(6):2240-2245. doi: 10.1111/ajt.16500. Epub 2021 Feb 8.
9
β-blockers in advanced cirrhosis: More friend than enemy.β受体阻滞剂在晚期肝硬化中的应用:利大于弊。
Clin Mol Hepatol. 2021 Jul;27(3):425-436. doi: 10.3350/cmh.2020.0234. Epub 2020 Dec 3.
10
High-density lipoprotein cholesterol is a predictor of survival in cirrhotic patients with acute gastrointestinal bleeding: a retrospective study.高密度脂蛋白胆固醇是肝硬化急性胃肠道出血患者生存的预测指标:一项回顾性研究。
BMC Gastroenterol. 2020 Nov 16;20(1):381. doi: 10.1186/s12876-020-01522-6.